MKI67 and neoplasm: Tumor size, the depth of myometrial invasion, tumor cell labeling of proliferation marker Ki67 (Figures 5(c)-5(d)), and the presence or absence of lymphovascular invasion were recorded as part of clinical and pathologic data.